Skip to main content
. 2018 Nov 29;9:709. doi: 10.3389/fendo.2018.00709

Figure 2.

Figure 2

The association between promoter methylation in NLRP3, AIM2, and ASC genes and T2DM complication (T2DM without any complication vs. T2DM with microvascular complications; T2DM without any complication vs. T2DM with macrovascular complications; T2DM without any complication vs. T2DM with both microvascular and macrovascular complications). (A) NLRP3 total methylation level; (B) NLRP3 each CpG methylation level; (C) AIM2 total methylation level; (D) AIM2 each CpG methylation level; (E) ASC total methylation level; (F) ASC each CpG methylation level. The Kruskal-Wallis test was used among T2DM subgroups and a Dunn-Bonferroni test for post-hoc comparisons, * Bonferroni-corrected P < 0.05, ** Bonferroni-corrected P < 0.001.